Apogee Therapeutics (APGE) News Today $53.40 -2.45 (-4.39%) Closing price 10/16/2025 04:00 PM EasternExtended Trading$55.71 +2.31 (+4.32%) As of 08:19 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock APGE Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Apogee Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $345 MillionOctober 10, 2025 | markets.businessinsider.comApogee Therapeutics (NASDAQ:APGE) Sees Unusually-High Trading Volume - What's Next?October 10, 2025 | marketbeat.comApogee Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $345 MillionOctober 10, 2025 | globenewswire.comApogee Therapeutics (APGE): Assessing Valuation Following $300 Million Equity RaiseOctober 10, 2025 | finance.yahoo.comDoes Apogee Therapeutics' (APGE) $300 Million Raise Mark a Shift in Its R&D Ambition?October 10, 2025 | finance.yahoo.comApogee Therapeutics (NASDAQ:APGE) Given "Buy" Rating at BTIG ResearchOctober 10, 2025 | marketbeat.comBTIG Reiterates Apogee Therapeutics (APGE) Buy RecommendationOctober 10, 2025 | msn.comApogee Therapeutics price target lowered to $82 from $87 at BofAOctober 9, 2025 | msn.comWhy Apogee, A Rival To Regeneron And Sanofi, Rocketed 34% And Broke OutOctober 9, 2025 | msn.comWhy Apogee Therapeutics Stock Triumphed on ThursdayOctober 9, 2025 | fool.comApogee Therapeutics' (APGE) "Sell (D-)" Rating Reiterated at Weiss RatingsOctober 9, 2025 | marketbeat.comApogee Therapeutics, Inc. Announces Pricing of $300 Million Underwritten Public OfferingOctober 8, 2025 | globenewswire.comApogee Therapeutics rises 14.5%October 8, 2025 | msn.comApogee Therapeutics stock falls after announcing proposed public offeringOctober 8, 2025 | za.investing.comApogee Therapeutics, Inc. Announces Proposed Underwritten Public OfferingOctober 8, 2025 | globenewswire.comApogee Therapeutics (NASDAQ:APGE) Trading Up 6.9% - Here's What HappenedOctober 8, 2025 | marketbeat.comApogee Therapeutics (NASDAQ:APGE) Insider Sells $203,378.00 in StockOctober 4, 2025 | insidertrades.comApogee Therapeutics (NASDAQ:APGE) Insider Carl Dambkowski Sells 5,110 SharesOctober 3, 2025 | marketbeat.comApogee Therapeutics Inc. $APGE Stock Position Decreased by Platinum Investment Management Ltd.October 2, 2025 | marketbeat.comRBC Capital Initiates Coverage of Apogee Therapeutics (APGE) With an Outperform RatingSeptember 30, 2025 | msn.comRBC Capital Initiates Coverage of Apogee Therapeutics (APGE) with Outperform RecommendationSeptember 25, 2025 | msn.comApogee Therapeutics (NASDAQ:APGE) Now Covered by Royal Bank Of CanadaSeptember 25, 2025 | marketbeat.comApogee Therapeutics initiated with an Outperform at RBC CapitalSeptember 25, 2025 | msn.comVoya Investment Management LLC Sells 24,533 Shares of Apogee Therapeutics Inc. $APGESeptember 25, 2025 | marketbeat.comApogee Therapeutics Inc. (NASDAQ:APGE) Receives Consensus Rating of "Moderate Buy" from AnalystsSeptember 24, 2025 | marketbeat.comBofA Raises Apogee Therapeutics (APGE) PT to $87 Following Positive Phase 2 APEX Trial Results for Atopic DermatitisSeptember 15, 2025 | msn.comSiren L.L.C. Sells 152,331 Shares of Apogee Therapeutics Inc. $APGESeptember 13, 2025 | marketbeat.comApogee Therapeutics (APGE) To Showcase APG777 At EADV Congress 2025September 12, 2025 | finance.yahoo.comWoodline Partners LP Has $39.64 Million Stock Holdings in Apogee Therapeutics Inc. $APGESeptember 12, 2025 | marketbeat.comApogee Therapeutics Announces Late-Breaker Presentation of 16-Week Data from Phase 2 APEX Trial of APG777 for Moderate-to-Severe Atopic Dermatitis at the Upcoming European ...September 11, 2025 | markets.businessinsider.comApogee Therapeutics Announces Late-Breaker Presentation of 16-Week Data from Phase 2 APEX Trial of APG777 for Moderate-to-Severe Atopic Dermatitis at the Upcoming European Academy of Dermatology and Venereology (EADV) 2025 CongressSeptember 11, 2025 | globenewswire.comOctagon Capital Advisors LP Acquires New Holdings in Apogee Therapeutics Inc. $APGESeptember 11, 2025 | marketbeat.comAlliancebernstein L.P. Decreases Stock Holdings in Apogee Therapeutics Inc. $APGESeptember 9, 2025 | marketbeat.comApogee Therapeutics Inc. $APGE Stake Reduced by Parkman Healthcare Partners LLCSeptember 8, 2025 | marketbeat.comGranahan Investment Management LLC Has $4.05 Million Stock Position in Apogee Therapeutics Inc. $APGESeptember 7, 2025 | marketbeat.comApogee Therapeutics Inc. $APGE Shares Bought by Adage Capital Partners GP L.L.C.September 7, 2025 | marketbeat.comApogee Therapeutics Inc. $APGE Shares Sold by Northern Trust CorpSeptember 7, 2025 | marketbeat.comApogee Therapeutics (NASDAQ:APGE) Insider Sells $103,195.75 in StockSeptember 6, 2025 | insidertrades.comApogee Therapeutics Inc. $APGE Shares Bought by Allostery Investments LPSeptember 5, 2025 | marketbeat.comADAR1 Capital Management LLC Buys 63,579 Shares of Apogee Therapeutics Inc. $APGESeptember 4, 2025 | marketbeat.comBirchview Capital LP Purchases Shares of 8,000 Apogee Therapeutics Inc. $APGESeptember 4, 2025 | marketbeat.comApogee Therapeutics to Participate at the Stifel 2025 Virtual Immunology and Inflammation ForumSeptember 3, 2025 | globenewswire.comRafferty Asset Management LLC Has $1.61 Million Holdings in Apogee Therapeutics Inc. $APGESeptember 3, 2025 | marketbeat.comParadigm Biocapital Advisors LP Sells 322,059 Shares of Apogee Therapeutics Inc. $APGESeptember 2, 2025 | marketbeat.comApogee Therapeutics Inc. (NASDAQ:APGE) Receives Consensus Recommendation of "Moderate Buy" from AnalystsSeptember 1, 2025 | marketbeat.comDriehaus Capital Management LLC Cuts Position in Apogee Therapeutics Inc. $APGEAugust 31, 2025 | marketbeat.comNuveen LLC Makes New $4.14 Million Investment in Apogee Therapeutics Inc. $APGEAugust 29, 2025 | marketbeat.comAffinity Asset Advisors LLC Has $43.01 Million Stake in Apogee Therapeutics Inc. $APGEAugust 28, 2025 | marketbeat.comApogee Therapeutics Inc. $APGE Shares Sold by Vanguard Group Inc.August 26, 2025 | marketbeat.comWellington Management Group LLP Raises Holdings in Apogee Therapeutics Inc. $APGEAugust 23, 2025 | marketbeat.com Get Apogee Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for APGE and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. APGE Media Mentions By Week APGE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. APGE News Sentiment▼0.250.68▲Average Medical News Sentiment APGE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. APGE Articles This Week▼75▲APGE Articles Average Week Get the Latest News and Ratings for APGE and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Apogee Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies MRUS News Today RNA News Today GRFS News Today CYTK News Today RYTM News Today ABVX News Today CRSP News Today NUVL News Today AXSM News Today LEGN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:APGE) was last updated on 10/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apogee Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Apogee Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
